Published in Science on December 03, 2010
Taking down 'the Ivory Tower': leveraging academia for better health outcomes in Uganda. BMC Int Health Hum Rights (2011) 1.25
Global health: the Fogarty International Center, National Institutes of Health: vision and mission, programs, and accomplishments. Infect Dis Clin North Am (2011) 1.14
Medical and nursing students' intentions to work abroad or in rural areas: a cross-sectional survey in Asia and Africa. Bull World Health Organ (2014) 1.12
HIV management by nurse prescribers compared with doctors at a paediatric centre in Gaborone, Botswana. S Afr Med J (2011) 0.98
Strengthening research capacity through the medical education partnership initiative: the Mozambique experience. Hum Resour Health (2013) 0.98
Maximizing the Impact of Training Initiatives for Health Professionals in Low-Income Countries: Frameworks, Challenges, and Best Practices. PLoS Med (2015) 0.97
Surgery and anesthesia capacity-building in resource-poor settings: description of an ongoing academic partnership in Uganda. World J Surg (2013) 0.90
Educating enough competent health professionals: advancing educational innovation at Muhimbili University of Health and Allied Sciences, Tanzania. PLoS Med (2012) 0.89
The US distribution of physicians from lower income countries. PLoS One (2012) 0.87
The importance of research in the MEPI program: perspectives from the National Institutes of Health. Acad Med (2014) 0.86
New academic partnerships in global health: innovations at Mount Sinai School of Medicine. Mt Sinai J Med (2011) 0.86
Human resources for primary health care in sub-Saharan Africa: progress or stagnation? Hum Resour Health (2015) 0.83
Innovative strategies for transforming internal medicine residency training in resource-limited settings: the Mozambique experience. Acad Med (2014) 0.81
Innovations to enhance the quality of health professions education at the University of Zimbabwe College of Health Sciences--NECTAR program. Acad Med (2014) 0.80
Building capacity in implementation science research training at the University of Nairobi. Implement Sci (2016) 0.75
Science and government. Obama and the promotion of international science. Science (2012) 0.75
Quality Assurance for African Laboratories: How Soon can this be Accomplished? N Am J Med Sci (2014) 0.75
Health Workforce Development with a Focus on CVD in Zimbabwe CHRIS Program, a Medical Education Partnership Initiative. Glob Heart (2011) 0.75
Universities form research partnership to improve care in Mozambique. Bull Am Coll Surg (2015) 0.75
Population Health Science: A Core Element of Health Science Education in Sub-Saharan Africa. Acad Med (2017) 0.75
Building local capacity for genomics research in Africa: recommendations from analysis of publications in Sub-Saharan Africa from 2004 to 2013. Glob Health Action (2016) 0.75
The Medical Education Partnership Initiative (MEPI), a collaborative paradigm for institutional and human resources capacity building between high- and low- and middle-income countries: the Mozambique experience. Glob Health Action (2017) 0.75
Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis (2003) 9.44
Grand challenges in global mental health. Nature (2011) 8.40
Grand challenges in chronic non-communicable diseases. Nature (2007) 7.86
Rotavirus and severe childhood diarrhea. Emerg Infect Dis (2006) 7.80
Norovirus classification and proposed strain nomenclature. Virology (2005) 7.69
Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis (2008) 7.48
Epidemiologic and molecular trends of "Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States. J Infect Dis (2002) 4.88
Public health. Implementation science. Science (2007) 4.33
Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Defic Syndr (2011) 3.77
Global mortality associated with rotavirus disease among children in 2004. J Infect Dis (2009) 3.63
Molecular and epidemiologic trends of caliciviruses associated with outbreaks of acute gastroenteritis in the United States, 2000-2004. J Infect Dis (2005) 3.16
Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus--United States, 2002. J Infect Dis (2004) 2.88
Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis (2005) 2.82
Use of TaqMan real-time reverse transcription-PCR for rapid detection, quantification, and typing of norovirus. J Clin Microbiol (2006) 2.82
Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics (2007) 2.75
The Chinese free antiretroviral treatment program: challenges and responses. AIDS (2007) 2.73
The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis (2012) 2.70
Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science (2009) 2.67
The promise of new rotavirus vaccines. N Engl J Med (2006) 2.58
Norovirus and foodborne disease, United States, 1991-2000. Emerg Infect Dis (2005) 2.57
Can nurse practitioners and physicians beat parochialism into plowshares? Health Aff (Millwood) (2002) 2.49
Public health. A major environmental cause of death. Science (2011) 2.32
Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis (2009) 2.12
Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006. J Clin Microbiol (2009) 2.06
Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 2.05
Reevaluation of epidemiological criteria for identifying outbreaks of acute gastroenteritis due to norovirus: United States, 1998-2000. Clin Infect Dis (2006) 2.05
Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs. JAMA (2010) 1.98
Diagnostic microbiologic methods in the GEMS-1 case/control study. Clin Infect Dis (2012) 1.98
Rotavirus antigenemia in patients with acute gastroenteritis. J Infect Dis (2005) 1.89
The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States. J Infect Dis (2012) 1.89
Real-world impact of rotavirus vaccination. Pediatr Infect Dis J (2011) 1.89
United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Pediatr Infect Dis J (2011) 1.83
The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines. Rev Panam Salud Publica (2004) 1.80
Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol (2004) 1.79
Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics (2006) 1.64
The global burden of diarrhoeal disease in children. Bull World Health Organ (2003) 1.61
Scientific rationale for a change in the composition of oral rehydration solution. JAMA (2004) 1.57
A waterborne outbreak of Norwalk-like virus among snowmobilers-Wyoming, 2001. J Infect Dis (2002) 1.54
The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis (2002) 1.53
Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years. J Infect Dis (2009) 1.49
Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J (2010) 1.48
A way forward: the National HIV/AIDS Strategy and reducing HIV incidence in the United States. J Acquir Immune Defic Syndr (2010) 1.48
Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis (2005) 1.47
Perceived threats and real killers. Science (2004) 1.41
Human caliciviruses as a cause of severe gastroenteritis in Peruvian children. J Infect Dis (2004) 1.37
Are noroviruses emerging? Emerg Infect Dis (2005) 1.36
Foodborne viral gastroenteritis: challenges and opportunities. Clin Infect Dis (2002) 1.35
Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J (2006) 1.35
Widespread outbreak of norovirus gastroenteritis among evacuees of Hurricane Katrina residing in a large "megashelter" in Houston, Texas: lessons learned for prevention. Clin Infect Dis (2007) 1.34
Global impact of rotavirus vaccines. Expert Rev Vaccines (2010) 1.34
Norovirus transmission on cruise ship. Emerg Infect Dis (2005) 1.33
Detection of viral agents in fecal specimens of monkeys with diarrhea. J Med Primatol (2007) 1.29
Diversity of rotavirus strains among children with acute diarrhea in China: 1998-2000 surveillance study. J Clin Microbiol (2002) 1.29
The global alliance for chronic diseases. Science (2009) 1.23
Bridging health research and policy: effective dissemination strategies. J Public Health Manag Pract (2008) 1.22
Sentinel hospital surveillance for rotavirus diarrhea in the People's Republic of China, August 2001-July 2003. J Infect Dis (2005) 1.22
Evaluation and comparison of two commercial enzyme-linked immunosorbent assay kits for detection of antigenically diverse human noroviruses in stool samples. J Clin Microbiol (2004) 1.21
PEPFAR's past and future efforts to cut costs, improve efficiency, and increase the impact of global HIV programs. Health Aff (Millwood) (2012) 1.18
Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries. Pediatr Infect Dis J (2013) 1.17
Use of active surveillance to validate international classification of diseases code estimates of rotavirus hospitalizations in children. Pediatrics (2005) 1.17
Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis (2005) 1.17
Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine (2008) 1.17
Is Option B+ the best choice? Lancet (2013) 1.16
Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatr Infect Dis J (2003) 1.15
The globalization of health research: harnessing the scientific diaspora. Acad Med (2009) 1.15
Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets. Vaccine (2010) 1.14
Global health: the Fogarty International Center, National Institutes of Health: vision and mission, programs, and accomplishments. Infect Dis Clin North Am (2011) 1.14
Epidemiological profile and burden of rotavirus diarrhea in Vietnam: 5 years of sentinel hospital surveillance, 1998-2003. J Infect Dis (2005) 1.13
Assessment of the epidemic potential of a new strain of rotavirus associated with the novel G9 serotype which caused an outbreak in the United States for the first time in the 1995-1996 season. J Clin Microbiol (2004) 1.13
A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy. J Infect Dis (2013) 1.12
Outbreaks of adult gastroenteritis traced to a single genotype of rotavirus. J Infect Dis (2002) 1.11
The epidemiology and burden of rotavirus in China: a review of the literature from 1983 to 2005. Vaccine (2006) 1.11
The pathology of rotavirus-associated deaths, using new molecular diagnostics. Clin Infect Dis (2003) 1.10
Immunogenicity of a thermally inactivated rotavirus vaccine in mice. Hum Vaccin (2007) 1.08
Rotavirus vaccines--early success, remaining questions. N Engl J Med (2009) 1.07
G and P types of circulating rotavirus strains in the United States during 1996-2005: nine years of prevaccine data. J Infect Dis (2009) 1.07
Update on rotavirus vaccines. Pediatr Infect Dis J (2005) 1.06
Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine (2006) 1.05
Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children. Vaccine (2004) 1.05
Rotavirus disease and its prevention. Curr Opin Gastroenterol (2005) 1.05
Astrovirus acute gastroenteritis among children in Madrid, Spain. Pediatr Infect Dis J (2002) 1.05
Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea. J Virol (2007) 1.05
Rotavirus strain surveillance in Latin America: a review of the last nine years. Pediatr Infect Dis J (2004) 1.04
Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J Clin Microbiol (2005) 1.03
Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination. Pediatr Infect Dis J (2007) 1.02
Rotavirus: realising the potential of a promising vaccine. Lancet (2010) 1.02
Household air pollution in low- and middle-income countries: health risks and research priorities. PLoS Med (2013) 1.02
The expanding diversity of rotaviruses. Lancet (2002) 1.01
The epidemiology of rotavirus diarrhea in countries in the Eastern Mediterranean Region. J Infect Dis (2010) 1.01
Temporal and geographic trends of rotavirus activity in the United States, 1997-2004. Pediatr Infect Dis J (2006) 1.00
Prevalence of rotavirus and norovirus antibodies in non-human primates. J Med Primatol (2004) 0.99
Detection and characterisation of human astroviruses in children with acute gastroenteritis in Blantyre, Malawi. J Med Virol (2002) 0.99
Hospital-based study of the economic burden associated with rotavirus diarrhea in Hong Kong. J Infect Dis (2005) 0.98
Incidence of rotavirus diarrhea and intussusception in Hong Kong using standardized hospital discharge data. Pediatr Infect Dis J (2002) 0.98
Norovirus detection and genotyping for children with gastroenteritis, Brazil. Emerg Infect Dis (2007) 0.97
Estimates of rotavirus disease burden in Hong Kong: hospital-based surveillance. J Infect Dis (2005) 0.96
Quantitative evaluation of rotaviral antigenemia in children with acute rotaviral diarrhea. J Infect Dis (2006) 0.96
Importance and challenges of accurately counting rotavirus deaths in China, 2002. Vaccine (2009) 0.96
Public health. Progress toward rotavirus vaccines. Science (2006) 0.95
Serum IgG mediates mucosal immunity against rotavirus infection. Proc Natl Acad Sci U S A (2005) 0.95